Skip to main content

Day: October 16, 2025

Apollo Files NI 43-101 Technical Report for the Calico Silver Project Updated Mineral Resource Estimate

VANCOUVER, British Columbia, Oct. 16, 2025 (GLOBE NEWSWIRE) — Apollo Silver Corp. (“Apollo” or the “Company”) (TSX.V:APGO, OTCQB:APGOF, Frankfurt:6ZF) is pleased to announce that it has filed the independent technical report for the updated Mineral Resource Estimate (“MRE”) for the Calico Silver Project (“Calico” or the “Calico Project”). The report titled “NI 43-101 Technical Report and Mineral Resource Estimate for the Calico Silver Project, San Bernardino County, California, USA”, is dated October 16, 2025 (with an effective date of June 30, 2025) (the “Technical Report”). The Technical Report is available under the Company’s issuer profile on SEDAR+ (www.sedarplus.ca) and on the Company’s website (www.apollosilver.com). The Technical Report was prepared in accordance with National Instrument 43-101 (“NI 43-101”) Standards of...

Continue reading

South Bow Announces Timing of Third-quarter 2025 Results and Conference Call and Webcast

CALGARY, Alberta, Oct. 16, 2025 (GLOBE NEWSWIRE) — South Bow Corp. (TSX & NYSE: SOBO) (South Bow or the Company) will release its third-quarter 2025 financial and operational results after the close of markets on Nov. 13, 2025. Conference call and webcast details South Bow’s senior leadership will host a conference call and webcast to discuss the Company’s third-quarter 2025 results and 2026 outlook on Nov. 14, 2025 at 8 a.m. MT (10 a.m. ET).   Date Nov. 14, 2025Time 8 a.m. MT (10 a.m. ET)Conference call link https://register-conf.media-server.com/register/BI7d28e530fb654087a3a1bb5a2c17892dWebcast link https://edge.media-server.com/mmc/p/i7eevia6Register ahead of time to receive a unique PIN to access the conference call via telephone. Once registered, participants can dial into the conference...

Continue reading

AVITA Medical Announces CEO Transition

Board Chairman Cary Vance appointed Interim CEO Board member Jan Stern Reed appointed Lead Independent Director Third quarter 2025 preliminary revenue expected to be approximately $17 millionVALENCIA, Calif., Oct. 16, 2025 (GLOBE NEWSWIRE) — AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH) (“AVITA Medical”, or the “Company”), a leading therapeutic acute wound care company, today announced that the Board of Directors has named Chairman of the Board Cary Vance as Interim Chief Executive Officer, effective immediately. In conjunction with this appointment, Jim Corbett is leaving his positions as CEO and member of the Board. Mr. Vance will continue to serve as Chairman of the Board, while Board member Jan Stern Reed has been appointed Lead Independent Director. The Board intends to engage an executive search firm to assist with selecting...

Continue reading

Salem Media Group Announces the Issuance of SALM Stock to Co-Founder and Executive Chairman, Edward G. Atsinger III, in Lieu of Cash, and the Removal of Stock Forfeiture Provision for Previous Restricted Stock Grants

CAMARILLO, Calif., Oct. 16, 2025 (GLOBE NEWSWIRE) — Salem Media Group, Inc. (OTCQX: SALM) announced today that Edward G. Atsinger III, Co-Founder and Executive Chairman of the Company, has agreed to receive the remaining portion of his 2025 compensation in the form of Restricted Class A Common Stock rather than cash. This decision reflects Mr. Atsinger’s continued commitment to the long-term success and stability of the Company. The stock award, totaling 218,067 shares (“Stock Compensation”), represents the cash compensation amount due for the period between September 21, 2025, and December 31, 2025, totaling $168,500. The Stock Compensation will vest twelve (12) months from the grant date and will not be subject to any other vesting restrictions. Additionally, in January 2025, Mr. Atsinger was granted 400,000 Restricted Class...

Continue reading

Cartier Silver Announces Upsize of Previously Announced Brokered Private Placement to $2.0M Led by Centurion One Capital

Not for distribution to U.S. newswire services or for release, publication, distribution or dissemination, directly or indirectly, in whole or in part, into the United States TORONTO, Oct. 16, 2025 (GLOBE NEWSWIRE) — Cartier Silver Corporation (CSE: CFE) (“Cartier Silver” or the “Company”) is pleased to announce that it has upsized its brokered private placement as previously announced in its press release dated October 8, 2025, due to strong investor demand. Under the amended terms, the Company will issue up to 16,000,000 units (“Units”) of the Company at $0.125 per Unit (the “Issue Price”) for aggregate gross proceeds of up to approximately $2,000,000 (the “Offering”). Each Unit shall consist of one common share in the capital of the Company (each, a “Share”) and one-half of one Share purchase warrant (each, a “Warrant”). Each...

Continue reading

DPM Metals Announces Filing of Amended Technical Report for the Vareš Mine

TORONTO, Oct. 16, 2025 (GLOBE NEWSWIRE) — DPM Metals Inc. (TSX: DPM, ASX: DPM) (ARBN: 689370894) (“DPM” or “the Company”) announces that, as a result of a review (the “Review”) of the existing technical report on the Vareš Mine by staff of the Ontario Securities Commission (the “OSC”), the Company is issuing the following news release regarding disclosure on the Vareš Mine. In connection with the Review, the Company has amended and refiled the technical report entitled “NI 43-101 Technical Report on the Vareš Mine, Bosnia and Herzegovina” with an effective date of April 1, 2025, and an issue date of June 9, 2025 (the “Vareš Technical Report”). The revisions to the Vareš Technical Report consist of the following: (i) removing the disclosure whereby a minor amount of inferred mineral resources was included in the mining shapes constituting...

Continue reading

Disc Medicine Announces Receipt of FDA Commissioner’s National Priority Voucher (CNPV) for Bitopertin in Erythropoietic Protoporphyria (EPP)

Disc is seeking accelerated approval of bitopertin for patients aged 12 years and older with EPP The CNPV program is designed to reduce the drug application review process to 1-2 monthsWATERTOWN, Mass., Oct. 16, 2025 (GLOBE NEWSWIRE) — Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases, today announced that it received a Commissioner’s National Priority Voucher (CNPV) from the U.S. Food and Drug Administration (FDA) for bitopertin in erythropoietic protoporphyria (EPP), including X-linked protoporphyria (XLP). Disc submitted a New Drug Application (NDA) to the FDA for bitopertin for patients aged 12 years and older with EPP following the FDA’s accelerated approval...

Continue reading

Targa Resources Corp. Announces Quarterly Dividend and Timing of Third Quarter 2025 Earnings Webcast

HOUSTON, Oct. 16, 2025 (GLOBE NEWSWIRE) — Targa Resources Corp. (NYSE: TRGP) (“Targa” or the “Company”) announced today that its board of directors has declared a quarterly cash dividend of $1.00 per common share, or $4.00 per common share on an annualized basis, for the third quarter of 2025. This cash dividend will be paid November 17, 2025 on all outstanding common shares to holders of record as of the close of business on October 31, 2025. The Company will report its third quarter 2025 financial results before the market opens for trading on Wednesday, November 5, 2025, and will host a live webcast at 11:00 a.m. Eastern Time (10:00 a.m. Central Time) to discuss its 2025 third quarter financial results. Event InformationEvent: Targa Resources Corp. Third Quarter 2025 Earnings Webcast and PresentationDate: Wednesday,...

Continue reading

TC Energy to host third quarter 2025 conference call on Nov. 6

CALGARY, Alberta, Oct. 16, 2025 (GLOBE NEWSWIRE) — News Release – TC Energy Corporation (TSX, NYSE: TRP) (TC Energy or the Company) will hold a teleconference and webcast on Thursday, Nov. 6, 2025, to discuss its third quarter financial results. The event will also include an update to the Company’s financial outlook along with other developments. François Poirier, TC Energy President and Chief Executive Officer; Sean O’Donnell, Executive Vice-President and Chief Financial Officer, and other members of the executive leadership team will discuss the financial results as well as the Company’s 2026 strategic priorities, long-term strategic outlook and growth objectives at 6:30 a.m. MT / 8:30 a.m. ET. Members of the investment community and other interested parties are invited to participate by calling 1-833-752-3826 (Canada/U.S. toll...

Continue reading

ROCKET DOCTOR AI INC. ANNOUNCES ENGAGEMENT OF FN MEDIA GROUP

Vancouver, British Columbia, Oct. 16, 2025 (GLOBE NEWSWIRE) — Rocker Doctor AI Inc. (the “Company” or “Rocket Doctor AI”) (CSE: AIDR, OTC: AIRDF, Frankfurt: 939) announces that it has engaged FN Media Group, LLC (“FN Media”) to commence news/media marketing campaigns for a three (3) day term commencing the week of October 20, 2025, in  consideration of USD$14,085. FN Media shall utilize its proprietary traffic generation application and Google/Yahoo Digital media ads platforms. FN Media does not currently own any interest, directly or indirectly, in the Company or its securities. FN Media’s address is 49 N. Federal Hwy, #281, Pompano Beach, Florida, USA, 33062 (phone: (954) 345-0611, email: patrick@financialnewsmedia.com). FN Media and its directors and officers are arm’s length from the Company. About Rocket Doctor AI Inc. Rocket...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.